Status:
COMPLETED
Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
Centre Hospitalier Universitaire de Besancon
University Hospital, Strasbourg, France
Conditions:
Conotruncal Cardiac Defects
Eligibility:
All Genders
1+ years
Brief Summary
The investigators planned to study the etiopathogenic factors of conotruncal cardiac defects regarding the relations between the metabolic, the genetic and the environmental factors which lead to thes...
Eligibility Criteria
Inclusion
- Conotruncal cardiac defects patients and theirs mothers
- Weight: \> 3750 g
Exclusion
- Syndromic conotruncal cardiac defects
- 22q11 deletion Holder's
- Patients whose mother's took anti-folates before and during first pregnancy semester
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01460316
Start Date
October 1 2011
Last Update
January 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Cardiologie Pédiatrique, CHU Brabois Enfants
Vandœuvre-lès-Nancy, France, 54500